endometrial cancer

December 6, 2019December 6, 2019

Sutro’s Investigational Antibody-Drug Conjugate Shows Promise in Advanced Ovarian Cancer Phase 1 Trial

News

STRO-002, an investigational antibody-drug conjugate being developed by Sutro Biopharma, is safe and shows promising efficacy in women with advanced ovarian, fallopian tube, or primary peritoneal cancer, early Phase 1 ... Read more

March 6, 2019

FPA150 Trial Begins Dosing Ovarian, Breast, Endometrial Cancer Patients

News

Five Prime Therapeutics’ ongoing Phase 1 clinical trial has advanced to its Phase 1b expansion portion, in which researchers have begun giving breast, ovarian, and endometrial cancer patients an optimal dose ... Read more

November 2, 2018

Compugen, Bristol-Myers Squibb Collaborating to Test COM701, Opdivo Combo for Ovarian, Other Cancers

News

Compugen has entered into a clinical trial collaboration with Bristol-Myers Squibb (BMS) to evaluate the safety and preliminary effectiveness of its investigational immunotherapy COM701 in combination with BMS’ Opdivo (nivolumab), in a ... Read more

August 8, 2018

Women Who Had Assisted Reproduction at Greater Risk of Ovarian, Breast Cancers, Study Says

News

Women in the United Kingdom who had assisted reproduction are at greater risk of developing ovarian cancer and in situ breast cancer than the general population, a study found. But ... Read more

October 14, 2016October 14, 2016

Patients with Advanced Ovarian Cancer Seen to Benefit from Oral Therapy in Phase 2 Trial

News

Ovarian cancer patients who are refractory to platinum-based chemotherapy may significantly benefit from the investigative treatment selinexor, according to the results of a Phase 2 clinical trial recently presented at the European ... Read more